PharmaCyte Biotech, Inc. Uncategorized Contracts & Agreements
30 Contracts & Agreements
- Engagement Letter, dated May 9, 2023 by and between Synaptogenix, Inc. and Katalyst Securities LLC (Filed With SEC on May 11, 2023)
- Form of Director Offer Letter (Filed With SEC on August 16, 2022)
- Description of Securities (Filed With SEC on July 28, 2022)
- Description of Securities (Filed With SEC on August 10, 2021)
- Amendment No. 1 to Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated July 15, 2020 (Filed With SEC on September 11, 2020)
- Right of First Refusal Agreement by and between PharmaCyte Biotech, Inc. and Silver Rock Associates, Inc., dated May 4, 2020 (Filed With SEC on September 11, 2020)
- Second Amendment to Licensing Agreement between the Company and Austrianova Singapore Pte. Ltd. effective May 14, 2018 (Filed With SEC on May 15, 2018)
- Third Amendment to Licensing Agreement between the Company and Austrianova Singapore Pte. Ltd. effective May 14, 2018 (Filed With SEC on May 15, 2018)
- Letter Agreement between the Company and Dr. Tong dated October 9, 2017 (Filed With SEC on October 10, 2017)
- [Signaturepage follows] (Filed With SEC on July 10, 2017)
- [Signature page to follow] (Filed With SEC on May 2, 2017)
- 23046 Avenida de la Carlota| Suite 600 | Laguna Hills | California 92653 Office: 917 ###-###-#### |Fax: 917 ###-###-#### | Mobile: 917 ###-###-#### | ***@*** (Filed With SEC on March 13, 2017)
- FOURTHSTOCK OPTION AGREEMENT (Filed With SEC on March 13, 2017)
- ThirdSTOCK OPTION AGREEMENT (Filed With SEC on March 13, 2017)
- FOURTHSTOCK OPTION AGREEMENT (Filed With SEC on March 13, 2017)
- AMENDMENT NO. 2 TO EXECUTIVECOMPENSATION AGREEMENT (Filed With SEC on March 13, 2017)
- AMENDMENT NO. 2 TO EXECUTIVE COMPENSATIONAGREEMENT (Filed With SEC on March 13, 2017)
- CHARDAN CAPITAL MARKETS (Filed With SEC on December 21, 2016)
- First Amendmentto Licensing Agreement (Filed With SEC on July 29, 2016)
- SecondAmendment toLicensingAgreement (Filed With SEC on July 29, 2016)
- First Amendment toLicensing Agreement (Filed With SEC on July 29, 2016)
- AMENDMENT NO. 1 TO EXECUTIVE COMPENSATIONAGREEMENT (Filed With SEC on March 8, 2016)
- AMENDMENT NO. 1 TO EXECUTIVE COMPENSATIONAGREEMENT (Filed With SEC on March 8, 2016)
- 12510 Prosperity Drive | Suite 310 | SilverSpring | Maryland 20904-1643 Office: 917 ###-###-#### | Fax: 917 ###-###-####| Mobile: 917 ###-###-#### | ***@*** (Filed With SEC on April 29, 2015)
- ExecutiveCompensation AGREEMENT (Filed With SEC on March 13, 2015)
- ExecutiveCompensation AGREEMENT (Filed With SEC on March 13, 2015)
- Licensing Agreement (Filed With SEC on December 15, 2014)
- MANUFACTURING FRAMEWORK AGREEMENT (Filed With SEC on August 4, 2014)
- Licensing Agreement (Filed With SEC on July 18, 2013)
- REAL ESTATE SALE AGREEMENT (Filed With SEC on March 22, 2010)
